Membrane dual-targeting probes: A promising strategy for fluorescence-guided prostate cancer surgery and lymph node metastases detection
暂无分享,去创建一个
Ling-ling Wu | Qingyang Zhang | Hai‐Yu Hu | N. Xing | Fei-ya Yang | Bojun Zheng | Qinghua Wang | Qinxin Zhao
[1] T. James,et al. A practical strategy to develop isoform-selective near-infrared fluorescent probes for human cytochrome P450 enzymes , 2021, Acta pharmaceutica Sinica. B.
[2] Juyoung Yoon,et al. Activatable fluorescent probes for in situ imaging of enzymes. , 2021, Chemical Society reviews.
[3] Yanbing Zhao,et al. Tailoring Aggregation Extent of Photosensitizers to Boost Phototherapy Potency for Eliciting Systemic Antitumor Immunity , 2021, Advanced materials.
[4] Xiaohua Li,et al. Xanthene-Based NIR-II Dyes for In Vivo Dynamic Imaging of Blood Circulation. , 2021, Journal of the American Chemical Society.
[5] Jingming Zhang,et al. A prostate-specific membrane antigen activated molecular rotor for real-time fluorescence imaging , 2021, Nature Communications.
[6] A. Vahrmeijer,et al. Fundamentals and developments in fluorescence-guided cancer surgery , 2021, Nature Reviews Clinical Oncology.
[7] O. Dontsova,et al. Synthesis and Biological Evaluation of PSMA Ligands with Aromatic Residues and Fluorescent Conjugates Based on Them. , 2021, Journal of medicinal chemistry.
[8] E. Rosenthal,et al. Real-time fluorescence imaging in intraoperative decision making for cancer surgery. , 2021, The Lancet. Oncology.
[9] P. Roach,et al. A targeted near-infrared nanoprobe for deep-tissue penetration and imaging of prostate cancer. , 2021, Biomaterials science.
[10] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[11] Tonglei Li,et al. Intracellular uptake of nanocrystals: Probing with aggregation-induced emission of fluorescence and kinetic modeling , 2020, Acta pharmaceutica Sinica. B.
[12] Wei Wu,et al. In vivo dissolution of poorly water-soluble drugs: Proof of concept based on fluorescence bioimaging , 2020, Acta pharmaceutica Sinica. B.
[13] Hai‐Yu Hu,et al. A Pseudopaline Fluorescent Probe for the Selective Detection of Pseudomonas aeruginosa , 2020 .
[14] H. G. van der Poel,et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. , 2020, European urology.
[15] Jianjun Du,et al. Chemiluminescence for bioimaging and therapeutics: recent advances and challenges. , 2020, Chemical Society reviews.
[16] V. Brabec,et al. A New Multi-action Pt(IV) Conjugate with Oleate and Cinnamate Ligands Targets Human Epithelial Growth Factor Receptor HER2 in Aggressive Breast Cancer Cells. , 2020, Angewandte Chemie.
[17] Hong Wang,et al. Targeting castration-resistant prostate cancer with a novel RORγ antagonist elaiophylin , 2020, Acta pharmaceutica Sinica. B.
[18] A. Mottrie,et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. , 2020, European urology.
[19] N. Lawrentschuk,et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study , 2020, The Lancet.
[20] Ling-ling Wu,et al. Rapid differentiation between bacterial infections and cancer using a near-infrared fluorogenic probe† , 2020, Chemical science.
[21] Chang-ming Huang,et al. Safety and Efficacy of Indocyanine Green Tracer-Guided Lymph Node Dissection During Laparoscopic Radical Gastrectomy in Patients With Gastric Cancer: A Randomized Clinical Trial. , 2020, JAMA surgery.
[22] Zhen Cheng,et al. First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-I/II windows , 2019, Nature Biomedical Engineering.
[23] T. Maurer,et al. Image-Guided Surgery: Are We Getting the Most Out of Small-Molecule Prostate-Specific-Membrane-Antigen-Targeted Tracers? , 2019, Bioconjugate chemistry.
[24] Wei Zhou,et al. Sox7 negatively regulates prostate‐specific membrane antigen (PSMA) expression through PSMA‐enhancer , 2018, The Prostate.
[25] Xianlei Li,et al. In Situ Monitoring of MicroRNA Replacement Efficacy and Accurate Imaging‐Guided Cancer Therapy through Light‐Up Inter‐Polyelectrolyte Nanocomplexes , 2018, Advanced science.
[26] C. Stief,et al. 68Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer. , 2016, European urology.
[27] A. Burnett,et al. Erection rehabilitation following prostatectomy — current strategies and future directions , 2016, Nature Reviews Urology.
[28] H. Heinzer,et al. Initial Experience of (68)Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy. , 2016, European urology.
[29] M. Pomper,et al. Real-time, Near-Infrared Fluorescence Imaging with an Optimized Dye/Light Source/Camera Combination for Surgical Guidance of Prostate Cancer , 2014, Clinical Cancer Research.
[30] A. Hemal,et al. Fluorescence-enhanced robotic radical prostatectomy using real-time lymphangiography and tissue marking with percutaneous injection of unconjugated indocyanine green: the initial clinical experience in 50 patients. , 2014, European urology.
[31] Markus Graefen,et al. Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. , 2014, European urology.
[32] A. Fontana,et al. The biological activities of protein/oleic acid complexes reside in the fatty acid. , 2013, Biochimica et biophysica acta.
[33] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[34] Matthias D Hofer,et al. Prostate-specific membrane antigen expression as a predictor of prostate cancer progression. , 2007, Human pathology.
[35] D. Bostwick,et al. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma , 1998, Cancer.